Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_assertion type Assertion NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_head.
- NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_assertion description "[These results suggest that Liq treatment enhances glioma cell susceptibility to TMZ by inhibiting the PI3K/AKT/mTOR pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_provenance.
- NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_assertion evidence source_evidence_literature NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_provenance.
- NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_assertion SIO_000772 25351348 NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_provenance.
- NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_assertion wasDerivedFrom befree-2016 NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_provenance.
- NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_assertion wasGeneratedBy ECO_0000203 NP1233220.RAs2Lh78bp3DodFqEkNZxtSCO1X8f3NiXwGIQqwFR5pM8130_provenance.